TOBAF - TAAT Global Alternatives, Inc. Signs Non-Binding Letter of Intent to Acquire Premium Products LLC, Expanding Its Alternative Product Portfolio
(TheNewswire)
Vancouver, BC, January 17, 2025 – TheNewswire – TAAT Global Alternatives, Inc. ( CSE: TAAT )( OTCQX: TOBAF ) ( FRANKFURT:2TP ) (the “Company” or “TAAT”) ispleased to announce the signing of a non-binding Letter of Intentdated January 17, 2025 (the “LOI”) to acquire Premium Products LLC(“Premium Products”), an emerging distributor in the alternativeproduct space. This acquisition aligns with TAAT’s strategicobjectives to diversify its product offerings, tap into new marketopportunities, and accelerate revenue growth within theconsumer-packaged goods (CPG) sector.
Strategic Rationale for the Acquisition
The acquisition of Premium Products represents asignificant step forward in TAAT’s mission to innovate and disruptthe alternative product industry. Premium Products have a diverseproduct portfolio through its Delta-9 offerings which includechocolates, gummies, and disposable vape devices. Premium Productshave also developed partnerships to bring other innovative products tomarket, including non-tobacco nicotine alternatives andwellness-focused beverages, reinforcing its position in thealternative product space.
Transaction terms
The agreed acquisition price pursuant to the LOI is CAD$1,850,000, which is to be distributed as 10,882,353 common shares ofTAAT, issued at a deemed price of $0.17 per share to the members ofPremium Products. Key personnel of Premium Products will continue tosupport TAAT post-acquisition to ensure a smooth integration intoTAAT's business. The common shares issuable to the vendor inconnection with the acquisition will be subject to afour-month-and-one-day hold period from the date of issue pursuant toNational Instrument 45-106 (Prospectus Exemptions). The Company doesnot anticipate that there will be any finders’ fees payable on thistransaction, nor will there be a change of control or any new controlpersons created. Premium Products is an arm’s length party to theCompany.
The acquisition is subject to receipt of all necessaryregulatory approvals, including, as applicable, all required filingswith the Canadian Securities Exchange, completion of due diligencereasonable or customary in a transaction of a similar nature, andentering into a definitive agreement. The acquisition will notconstitute a fundamental change, within the meaning of the policies ofthe CSE.
TAAT’s Continued Organic Growth
TAAT continues to experience demand for its BeyondTobacco™ cigarettes, which provide a nicotine- and tobacco-freesmoking experience. This trend reflects broader consumer preferencesfor wellness-focused alternatives, particularly among adult smokersseeking healthier options. The acquisition enhances TAAT’s abilityto deliver a broader range of alternative products to meet evolvingconsumer demands.
On behalf of the Board of Directors of theCompany,
TAAT® GLOBAL ALTERNATIVES INC.
“Joel Dumaresq”
Joel Dumaresq, CFO and Director
For further information, please contact:
TAAT® Investor Relations
1-604-687-2038
investor@taatglobal.com
THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOTREVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY ORADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATIONSERVICES PROVIDER.
AboutTAAT Global Alternatives, Inc.
TAAT is a consumer product company specializing ininnovative alternatives to traditional CPG categories. With acommitment to quality and consumer satisfaction, TAAT operates fromits Ohio distribution center, fulfilling orders and supporting agrowing network of retail locations across the U.S.
For additional information, visit taatglobal.com
Forward-Looking Statements
Certain information contained herein may constitute"forward-looking information" or "forward-lookingstatements" under Canadian securities legislation. Generally,forward-looking information can be identified by words such as"pro forma", "plans", "expects","may", "should", "could","will", "budget", "scheduled","estimates", "forecasts", "intends","anticipates", "believes", or variations includingnegative variations thereof of such words and phrases that refer tocertain actions, events or results that may, occur or be taken orachieved. Such forward-looking statements, including but not limitedto statements relating to the expecteddevelopment and operations of the Company, including marketconditions, regulatory developments and the successful integration andperformance of Premium Products LLC within TAAT’s broader operationswhich involve risks, uncertainties and other factors which may causethe actual results to be materially different from those expressed orimplied by such forward-looking statements or forward-lookinginformation. There can be no assurance that such statements will proveto be accurate, as actual results and future events could differmaterially from those anticipated in such statements. Accordingly,readers should not place undue reliance on forward-looking statementsand forward-looking information. The Corporation will not update anyforward-looking statements or forward-looking information includedherein, except as required by applicable securities laws.
The statements in this news release have not beenevaluated by Health Canada or the U.S. Food and Drug Administration.As each individual is different, the benefits, if any, of taking theCompany’s products will vary from person to person. No claims orguarantees can be made as to the effects of the Company’s productson an individual’s health and well-being. The Company’s productsare not intended to diagnose, treat, cure, or prevent anydisease.
This news release may contain trademarked names ofthird-party entities (or their respective offerings with trademarkednames) typically in reference to (i) relationships had by the Companywith such third-party entities as referred to in this release and/or(ii) client/vendor/service provider parties whose relationship withthe Company is/are referred to in this release. All rights to suchtrademarks are reserved by their respective owners orlicensees.
Statement Regarding Third-PartyInvestor Relations Firms
Disclosures relating to investor relations firmsretained by TAAT® Global Alternatives Inc. can be found under theCompany's profile on www.sedarplus.ca .
Copyright (c) 2025 TheNewswire - All rights reserved.